The store will not work correctly when cookies are disabled.
2-(benzo[d][1,3]dioxol-5-yl)-5,7-dimethoxyquinolin-4(1H)-one
ID: ALA4214451
PubChem CID: 145972034
Max Phase: Preclinical
Molecular Formula: C18H15NO5
Molecular Weight: 325.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(OC)c2c(=O)cc(-c3ccc4c(c3)OCO4)[nH]c2c1
Standard InChI: InChI=1S/C18H15NO5/c1-21-11-6-13-18(17(7-11)22-2)14(20)8-12(19-13)10-3-4-15-16(5-10)24-9-23-15/h3-8H,9H2,1-2H3,(H,19,20)
Standard InChI Key: DQDFGRVUGHZTHX-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
2.3140 -16.2736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3128 -17.0932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0209 -17.5021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0191 -15.8648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7277 -16.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7311 -17.0907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4395 -17.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1491 -17.0849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1458 -16.2642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4328 -15.8545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4417 -18.3130 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8509 -15.8541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5602 -16.2622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2661 -15.8521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8471 -15.0403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6061 -15.8652 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0214 -18.3193 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3140 -18.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8985 -16.2740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5501 -14.6278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2653 -15.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8702 -14.4759 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5288 -13.7289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7130 -13.8229 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
7 11 2 0
12 13 2 0
13 14 1 0
14 21 2 0
20 15 2 0
15 12 1 0
9 12 1 0
1 16 1 0
3 17 1 0
17 18 1 0
16 19 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 325.32 | Molecular Weight (Monoisotopic): 325.0950 | AlogP: 2.94 | #Rotatable Bonds: 3 |
Polar Surface Area: 69.78 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.30 | CX Basic pKa: ┄ | CX LogP: 2.56 | CX LogD: 2.56 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.80 | Np Likeness Score: 0.34 |
References
1. Ling T, Lang W, Feng X, Das S, Maier J, Jeffries C, Shelat A, Rivas F.. (2018) Novel vitexin-inspired scaffold against leukemia., 146 [PMID:29407975] [10.1016/j.ejmech.2018.01.004] |